Advertisement

Rheumatology International

, Volume 39, Issue 7, pp 1279–1284 | Cite as

Urethral involvement in granulomatosis with polyangiitis: a case-based review

  • Hamdy M. A. AhmedEmail author
  • Mohanad M. Elfishawi
  • Ahmed Hagiga
  • Ibrahim M. A. Ahmed
  • Ya Li Chen
Cases with a Message
  • 18 Downloads

Abstract

Granulomatosis with polyangiitis (GPA) commonly presents with glomerulonephritis and inflammation of upper and lower respiratory tracts. It can also involve other organs including those of the urinary tract. The involvement of the urethra is very rarely reported. We present a case of GPA in a patient who had recurrent urinary tract infections and an acute bladder outlet obstruction due to a urethral thickening by GPA. In this report, we discuss urethral involvement with GPA. The incidence of such involvement, as with other urinary tract organs, might be underestimated. It can affect both sexes, with male predominance, and can occur at any age. It responds to standard GPA medical treatment but may require surgical intervention. Rheumatologists should be aware of this limited form of GPA as early recognition and treatment can decrease the risk of complications.

Keywords

Granulomatosis with polyangiitis GPA Wegener’s Urogenital Urethra Limited form 

Notes

Acknowledgements

The authors would like to express sincere gratitude to Dr. Alvin Lee Day for reviewing the manuscript and constructive feedback.

Author contributions

HMAA and YLC have summarized the case presentation. IMAA has translated the French case report into English. All authors have contributed to the literature review and to the manuscript.

Funding

Nothing to declare.

Compliance with ethical standards

Conflict of interest

The author(s) declare that they have no conflict of interest.

References

  1. 1.
    Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337(21):1512–1523.  https://doi.org/10.1056/nejm199711203372106 CrossRefGoogle Scholar
  2. 2.
    Lutalo PM, D’Cruz DP (2014) Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun 48–49:94–98.  https://doi.org/10.1016/j.jaut.2014.01.028 CrossRefGoogle Scholar
  3. 3.
    Seo P, Stone JH (2004) The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 117(1):39–50.  https://doi.org/10.1016/j.amjmed.2004.02.030 CrossRefGoogle Scholar
  4. 4.
    Jayne D (2009) The diagnosis of vasculitis. Best Pract Res Clin Rheumatol 23(3):445–453.  https://doi.org/10.1016/j.berh.2009.03.001 CrossRefGoogle Scholar
  5. 5.
    Reinhold-Keller E, Beuge N, Latza U, De Groot K, Rudert H, Nölle B et al (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43(5):1021–1032CrossRefGoogle Scholar
  6. 6.
    Group TWR (2002) Design of the Wegener’s granulomatosis etanercept trial (WGET). Control Clin Trials 23(4):450–468CrossRefGoogle Scholar
  7. 7.
    Stone JH (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum 48(8):2299–2309.  https://doi.org/10.1002/art.11075 CrossRefGoogle Scholar
  8. 8.
    Schnabel A, Holl-Ulrich K, Dalhoff K, Reuter M, Gross WL (1997) Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir J 10(12):2738–2743CrossRefGoogle Scholar
  9. 9.
    Masiak A, Zdrojewski Z, Pęksa R, Smoleńska Ż, Czuszyńska Z, Siemińska A et al (2017) The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis. Reumatologia 55:230–236.  https://doi.org/10.5114/reum.2017.71638 CrossRefGoogle Scholar
  10. 10.
    de Souza FH, Radu Halpern AS, Valente Barbas CS, Shinjo SK (2010) Wegener’s granulomatosis: experience from a Brazilian tertiary center. Clin Rheumatol 29(8):855–860.  https://doi.org/10.1007/s10067-010-1408-4 CrossRefGoogle Scholar
  11. 11.
    Alba MA, Moreno-Palacios J, Beca S, Cid MC (2015) Urologic and male genital manifestations of granulomatosis with polyangiitis. Autoimmun Rev 14(10):897–902.  https://doi.org/10.1016/j.autrev.2015.05.012 CrossRefGoogle Scholar
  12. 12.
    Huong DL, Papo T, Piette JC, Wechsler B, Bletry O, Richard F et al (1995) Urogenital manifestations of Wegener granulomatosis. Medicine (Baltimore). 74(3):152–161CrossRefGoogle Scholar
  13. 13.
    Dufour JF, Le Gallou T, Cordier JF, Aumaitre O, Pinede L, Aslangul E et al (2012) Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature. Medicine (Baltimore). 91(2):67–74.  https://doi.org/10.1097/MD.0b013e318239add6 CrossRefGoogle Scholar
  14. 14.
    Davenport A, Downey SE, Goel S, Maciver AG (1996) Wegener’s granulomatosis involving the urogenital tract. Br J Urol 78(3):354–357.  https://doi.org/10.1046/j.1464-410X.1996.00166.x CrossRefGoogle Scholar
  15. 15.
    Fowler M, Martin SA, Bowles WT, Packman R, Katzenstein A-L (1979) Wegener granulomatosis Unusual cause of necrotizing urethritis. Urology 14(1):66–69CrossRefGoogle Scholar
  16. 16.
    Jensen KE, Nielsen K, Kock K (1982) Necrotising urethritis in Wegener’s granulomatosis. Br J Urol. 54(4):434CrossRefGoogle Scholar
  17. 17.
    Dore B, Duriez P, Grange P, Aubert J (1990) Wegener’s granulomatosis with urethral-penile location: Apropos of a case. Ann Urol 24(3):256–258Google Scholar
  18. 18.
    Weiss R, Hrehorovich V (1991) An unusual manifestation of Wegener’s granulomatosis. Md Med J (Baltimore, Md: 1985) 40(4):271Google Scholar
  19. 19.
    Ter Maaten J, Franssen C, Daenekindt A, Hoorntje S (1993) Triple Wegener’s granulomatosis in the urogenital tract. Nephron 63(3):358–359CrossRefGoogle Scholar
  20. 20.
    Zielonka T, Madalinska M, Droszcz W, Pogorzelski R, Borkowski A (1995) Urethral stricture as unusual complications of Wegener’s granulomatosis. Neth J Med 46(5):236–238CrossRefGoogle Scholar
  21. 21.
    Linehan J, Bhakri H (1995) Penile granulomas with urethral stricture: unusual presentation of Wegener’s granulomatosis. Br J Clin Pract 49(1):47Google Scholar
  22. 22.
    Ebo D, Mertens A, De Clerck L, Gentens P, Daelemans R (1998) Relapse of Wegener’s granulomatosis presenting as a destructive urethritis and penile ulceration. Clin Rheumatol 17(3):239–241CrossRefGoogle Scholar
  23. 23.
    Sharma A, Gopalakrishan D, Nada R, Kumar S, Dogra S, Aggarwal MM et al (2014) Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades. Int J Rheum Dis 17(5):562–572CrossRefGoogle Scholar
  24. 24.
    Soro Marín S, Júdez Navarro E, Sianes Fernández M, Sánchez Nievas G, Romero JGL (2017) An Unusual presentation of limited granulomatosis with polyangiitis involving vagina and urethra. Case Rep Rheumatol.  https://doi.org/10.1155/2017/9407675 Google Scholar
  25. 25.
    Anderson PT, Gottheil S, Gabril M, Barra L, Power N (2017) Acute urinary retention secondary to urethral involvement of granulomatosis with polyangiitis. Can Urol Assoc J 11(1–2):E38CrossRefGoogle Scholar
  26. 26.
    Nielsen K, Jensen K, Kock K (1981) Wegener’s granulomatosis. A brief review and report of an unusual course with urethral localization. Ugeskrift for laeger 143(16):1003Google Scholar
  27. 27.
    Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498CrossRefGoogle Scholar
  28. 28.
    Tomasson G, Grayson PC, Mahr AD, LaValley M, Merkel PA (2012) Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis. Rheumatology (Oxford) 51(1):100–109.  https://doi.org/10.1093/rheumatology/ker280 CrossRefGoogle Scholar
  29. 29.
    Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P et al (2015) ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol 26(3):537–542.  https://doi.org/10.1681/asn.2013111233 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Rheumatology, Department of MedicineUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Department of Medicine, New York City Health Hospitals, QueensIcahn School of Medicine at Mount SinaiNew YorkUSA
  3. 3.Chelsea and Westminster Hospital NHS Foundation TrustLondonUK
  4. 4.Faculty of MedicineUniversity of BenhaBenhaEgypt
  5. 5.Division of Rheumatology, Department of MedicineRochester Regional Health SystemRochesterUSA

Personalised recommendations